Coleen A McNamara Selected Research

Coleen A McNamara Research Topics

Disease

27	Atherosclerosis 07/2022 - 09/2008
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2006
6	Insulin Resistance 01/2020 - 11/2006
5	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 01/2018
4	Obesity 01/2021 - 11/2015
3	Abdominal Aortic Aneurysm 12/2021 - 11/2014
3	Inflammation (Inflammations) 01/2021 - 04/2016
2	Ischemia 01/2022 - 01/2020
2	COVID-19 01/2021 - 01/2021
2	Necrosis 10/2019 - 01/2018
2	Dyslipidemias (Dyslipidemia) 01/2019 - 11/2006
2	Rupture 01/2018 - 11/2014
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2014
2	Hypertension (High Blood Pressure) 01/2018 - 01/2014
2	Vascular Diseases (Vascular Disease) 01/2017 - 10/2005
2	Type 2 Diabetes Mellitus (MODY) 09/2015 - 05/2008
2	Hyperlipidemias (Hyperlipidemia) 01/2014 - 01/2006
2	Vascular System Injuries 01/2006 - 03/2002
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2021
1	Abdominal Obesity 01/2021
1	Infections 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Cytokine Release Syndrome 01/2021
1	Pathologic Constriction (Stenosis) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Weight Loss (Weight Reduction) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2018
1	Diabetes Mellitus 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Neoplasms (Cancer) 11/2016
1	Autoimmune Diseases (Autoimmune Disease) 11/2016
1	Glucose Intolerance 04/2016
1	Glomerulonephritis 01/2014
1	Kidney Diseases (Kidney Disease) 01/2014
1	Chronic Renal Insufficiency 01/2014
1	Hypertrophy 02/2010
1	Hyperplasia 02/2010

Drug/Important Bio-Agent (IBA)

12	Immunoglobulin M (IgM)IBA 01/2022 - 01/2012
11	Apolipoproteins E (ApoE)IBA 01/2021 - 04/2010
8	AntibodiesIBA 01/2021 - 01/2012
7	EpitopesIBA 07/2022 - 12/2013
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2006
5	oxidized low density lipoproteinIBA 01/2022 - 01/2006
4	CytokinesIBA 07/2022 - 09/2008
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2013
3	Immunoglobulin E (IgE)IBA 01/2021 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2015
3	ApolipoproteinsIBA 01/2021 - 01/2014
3	Lipoproteins (Lipoprotein)IBA 01/2020 - 01/2014
3	CholesterolIBA 01/2019 - 05/2008
2	Apolipoproteins B (ApoB)IBA 07/2022 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 12/2021
2	ChemokinesIBA 01/2021 - 01/2014
2	Chemokine ReceptorsIBA 01/2021 - 10/2019
2	1-penicillamyl-Leu(2)- oxytocinIBA 01/2020 - 01/2018
2	AdiponectinIBA 01/2020 - 09/2008
2	CalciumIBA 01/2018 - 01/2014
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2016 - 05/2008
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2022
1	B-Cell Activation Factor ReceptorIBA 12/2021
1	B-Cell Maturation AntigenIBA 12/2021
1	B-Cell Activating FactorIBA 12/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	canakinumab FDA Link 01/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	IsoenzymesIBA 01/2021
1	tesaglitazarIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 10/2019
1	Malondialdehyde (Propanedial)IBA 10/2019
1	NucleotidesIBA 10/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	AutoantibodiesIBA 01/2018
1	AllergensIBA 01/2018
1	HDL LipoproteinsIBA 01/2018
1	OligosaccharidesIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	EnzymesIBA 01/2016
1	LDL Receptors (LDL Receptor)IBA 01/2016
1	Insulin (Novolin)FDA Link 09/2015
1	AntigensIBA 07/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2012
1	LipidsIBA 03/2012
1	Oxidants (Oxidizing Agents)IBA 02/2010

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2012
1	Length of Stay 01/2020
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2020